Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Daily Stock Ratings & Price Targets US
Analyst Performance
Any
Analyst Rating
Any
Upside / Downside
Any
Action
Any
Market Cap
Any
Analyst & Firm | Company | Price | Rating & Price Target | Upside / Downside | Success Rate | Average Return | Action | Date | Article |
|---|---|---|---|---|---|---|---|---|---|
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $7 | ― | 7.50% | Reiterated | ||||
 | Insmed | BUY $88 | ― | -9.90% | Reiterated | Wall Street Analysts Are Bullish on Top Healthcare Picks | |||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $116→$195 | ― | 25.10% | Downgraded | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $167→$100 | ― | 9.90% | Reiterated | ||||
| Cerence | BUY $16 | ― | -5.30% | Upgraded | Cerence upgraded to Buy from Hold at Needham | |||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $150→$135 | ― | 16.20% | Reiterated | ||||
 | Natera | BUY $185 | ― | -7.20% | Reiterated | Analysts Offer Insights on Healthcare Companies: Mersana Therapeutics (NASDAQ: MRSN) and Natera (NASDAQ: NTRA) | |||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $691 | ― | 19.40% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $41 | ― | 9.70% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $200 | ― | 19.80% | Reiterated | ||||
 | Align Tech | BUY $275 | ― | -2.10% | Assigned | Align Tech (ALGN) Gets a Buy from Piper Sandler | |||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $37 | ― | 0.60% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $65 | ― | 13.40% | Assigned | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $179 | ― | 13.40% | Assigned | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $91 | ― | 14.90% | Assigned | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $53 | ― | 12.20% | Assigned | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $59 | ― | 6.40% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $200→$210 | ― | 30.30% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $40 | ― | 11.90% | Assigned | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $151 | ― | 11.90% | Assigned | ||||
| Masimo | BUY $210 | ― | -2.10% | Assigned | Piper Sandler Sticks to Its Buy Rating for Masimo (MASI) | |||
| UnitedHealth | BUY $600 | ― | -4.30% | Assigned | Piper Sandler Sticks to Its Buy Rating for UnitedHealth (UNH) | |||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $440 | ― | 10.20% | Downgraded | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $325→$310 | ― | 13.60% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $120 | ― | 11.20% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $120 | ― | 11.90% | Assigned | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $120 | ― | 10.20% | Assigned | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $111 | ― | 11.90% | Assigned | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $68 | ― | 10.20% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $67 | ― | 10.70% | Assigned | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $55 | ― | 11.00% | Assigned | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $51 | ― | 5.10% | Assigned | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $35 | ― | 10.20% | Assigned | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $23 | ― | 14.90% | Assigned | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | SELL $22 | ― | 10.20% | Assigned | ||||
 | Ford Motor | HOLD $13→$11 | ― | -1.00% | Downgraded | Ford downgraded to Equal Weight from Overweight at Barclays | |||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $53 | ― | 5.60% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $345 | ― | 6.40% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $120 | ― | 16.40% | Upgraded | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $1,494 | ― | 6.00% | Upgraded | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $548→$540 | ― | 15.40% | Reiterated | ||||
| Lear | HOLD $120→$115 | ― | -1.00% | Reiterated | Lear price target lowered to $115 from $120 at Barclays | |||
| Visteon | BUY $140→$115 | ― | -1.00% | Reiterated | Visteon price target lowered to $115 from $140 at Barclays | |||
| Aptiv | BUY $80→$75 | ― | -1.00% | Reiterated | Aptiv price target lowered to $75 from $80 at Barclays | |||
| BorgWarner | BUY $47→$43 | ― | -1.00% | Reiterated | BorgWarner price target lowered to $43 from $47 at Barclays | |||
| Mobileye Global, Inc. Class A | BUY $18→$22 | ― | -1.00% | Reiterated | Mobileye price target raised to $22 from $18 at Barclays | |||
| Adient | HOLD $24→$21 | ― | -1.00% | Reiterated | Adient price target lowered to $21 from $24 at Barclays | |||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $13.25→$17.25 | ― | 3.20% | Reiterated | ||||
| Rivian Automotive | HOLD $13→$14 | ― | -1.00% | Reiterated | Rivian Automotive price target raised to $14 from $13 at Barclays | |||
| American Axle | HOLD $8→$7 | ― | -1.00% | Reiterated | American Axle price target lowered to $7 from $8 at Barclays |
Rows:
